SS
Sachin Shah
About Sachin Shah
Data last updated:
Sachin Shah is a Cfo at Eris Lifesciences Limited (since 2016), Director at Eris Therapeutics Limited (since 2021) and Director at Swiss Parenterals Limited (since 2024), and holds 7 more current directorships. The companies operate in Pharma, Machinery and Equipment and Life Sciences. The 5 current companies with reported revenue have a combined latest revenue of ₹6,263 Cr; the largest is Eris Lifesciences Limited at ₹5,069 Cr (FY 2025). Earlier, Sachin Shah was a Cfo at Eris Oaknet Healthcare Private Limited (2022–2024) and Director at Eris M. J. Biopharm Private Limited (2020–2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 28 Sep 2016 | 2007 | ₹5,069 Cr (FY 2025) | Active | |
| Director | 23 Jun 2021 | 2021 | ₹771 Cr (FY 2025) | Active | |
| Director | 15 Feb 2024 | 1997 | ₹232 Cr (FY 2023) | Active | |
| Director | 01 Oct 2017 | 2011 | ₹106 Cr (FY 2025) | Active | |
| Director | 01 Dec 2017 | 2013 | ₹85.67 Cr (FY 2025) | Active | |
| Director | 13 Sep 2024 | 2020 | Active | ||
| Director | 16 Oct 2026 | 2026 | Active | ||
| Director | 28 Feb 2025 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 26 Jul 2022 | 2011 | ₹253 Cr (FY 2023) | Active | |
| Director | 06 Aug 2020 | 2002 | ₹71.10 Cr (FY 2025) | Active | |
| Director | 23 Jan 2019 | 2016 | ₹56.30 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sachin Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sachin Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sachin Shah
Sachin Shah currently holds 10 directorships: Eris Lifesciences Limited (Cfo, since 28 Sep 2016, revenue ₹5,069 Cr (FY 2025)); Eris Therapeutics Limited (Director, since 23 Jun 2021, revenue ₹771 Cr (FY 2025)); Swiss Parenterals Limited (Director, since 15 Feb 2024, revenue ₹232 Cr (FY 2023)); Aprica Healthcare Limited (Director, since 01 Oct 2017, revenue ₹106 Cr (FY 2025)); Eris Healthcare Private Limited (Director, since 01 Dec 2017, revenue ₹85.67 Cr (FY 2025)); and 5 more.
Sachin Shah was first appointed on 28 Sep 2016 as Cfo at Eris Lifesciences Limited. The most recent appointment on record is 16 Oct 2026 at Aprica Pharma Limited.
The 5 current companies of Sachin Shah that report revenue have a combined latest revenue of ₹6,263 Cr: Eris Lifesciences Limited ₹5,069 Cr (FY 2025); Eris Therapeutics Limited ₹771 Cr (FY 2025); Swiss Parenterals Limited ₹232 Cr (FY 2023); Aprica Healthcare Limited ₹106 Cr (FY 2025); Eris Healthcare Private Limited ₹85.67 Cr (FY 2025).
Sachin Shah held 3 earlier board appointments: Eris Oaknet Healthcare Private Limited (Cfo, 26 Jul 2022 to 31 Dec 2024); Eris M. J. Biopharm Private Limited (Director, 06 Aug 2020 to 17 Dec 2021); Aprica Healthcare Limited (Director, from 23 Jan 2019).
The current boards of Sachin Shah's companies include Amit Indubhushan Bakshi (Eris Lifesciences Limited), Inderjeet Singh Negi (Eris Lifesciences Limited), Kalpana Vasantrai Unadkat (Eris Lifesciences Limited), Kaushal Kamlesh Shah (Eris Lifesciences Limited), Milind Talegaonkar (Eris Lifesciences Limited), Prashant Gupta (Eris Lifesciences Limited), among others.